Gene Salkind - 25 Aug 2023 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Gene Salkind
Issuer symbol
COEP
Transactions as of
25 Aug 2023
Net transactions value
+$30,107
Form type
4
Filing time
30 Aug 2023, 15:15:59 UTC
Previous filing
13 Apr 2023
Next filing
09 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $26,061 +28,638 $0.9100 28,638 25 Aug 2023 By Trust F1
transaction COEP Common Stock Purchase $4,046 +4,006 +10015% $1.01 4,046 29 Aug 2023 By Trust F3
holding COEP Common Stock 250,046 25 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the trustee.
F2 Includes (i) 84,217 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuable upon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that are issuable upon currently exercisable warrants and (iv) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable in the next 60 days. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.
F3 Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee.